We are live on ! Find out more
Schroder Investment Management Group

Schroder Investment Management Group Portfolio holdings

AUM $141B
1-Year Est. Return 34.18%
This Fund
S&P 500
This Quarter Est. Return
-2.16%
1 Year Est. Return
+34.18%
3 Year Est. Return
+121.7%
5 Year Est. Return
+159.58%
10 Year Est. Return
+619.19%
AUM
$99.1B
AUM Growth
-$5.32B
Cap. Flow
-$740M
Cap. Flow %
-0.75%
Top 10 Hldgs %
27.72%
Holding
1,277
New
83
Increased
445
Reduced
587
Closed
91

Top Buys

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$927M
2
AVGO icon
Broadcom
AVGO
+$406M
3
BLK icon
Blackrock
BLK
+$362M
4
CARR icon
Carrier Global
CARR
+$224M
5
LRCX icon
Lam Research
LRCX
+$172M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$325M
2
TSLA icon
Tesla
TSLA
+$304M
3
GEV icon
GE Vernova
GEV
+$283M
4
NVDA icon
NVIDIA
NVDA
+$280M
5
ZBRA icon
Zebra Technologies
ZBRA
+$277M

Sector Composition

Rank Sector Weight
1 Technology 26.33%
2 Financials 13.48%
3 Communication Services 12.67%
4 Consumer Discretionary 12.01%
5 Healthcare 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWG icon
826
iShares MSCI Germany ETF
EWG
$1.67B
$3.09M ﹤0.01%
+82,700
New +$2.95M
HES
827
DELISTED
Hess
HES
$3.06M ﹤0.01%
19,315
-230
-1% -$33.8K
RPRX icon
828
Royalty Pharma
RPRX
$26.1B
$3.05M ﹤0.01%
98,065
-98,294
-50% -$3.12M
NOV icon
829
NOV
NOV
$7.37B
$3.05M ﹤0.01%
200,167
-383,845
-66% -$5.74M
SJM icon
830
J.M. Smucker
SJM
$12.9B
$3.05M ﹤0.01%
26,182
+7,673
+41% +$829K
AXSM icon
831
Axsome Therapeutics
AXSM
$11.2B
$2.86M ﹤0.01%
24,142
– –
CGON icon
832
CG Oncology
CGON
$6.66B
$2.86M ﹤0.01%
+108,302
New +$3.05M
DXCM icon
833
DexCom
DXCM
$34.5B
$2.85M ﹤0.01%
42,083
-7,335
-15% -$599K
GPN icon
834
Global Payments
GPN
$25.1B
$2.85M ﹤0.01%
29,087
+1,831
+7% +$192K
EAT icon
835
Brinker International
EAT
$10.3B
$2.84M ﹤0.01%
+19,235
New +$2.96M
ROK icon
836
Rockwell Automation
ROK
$49.5B
$2.81M ﹤0.01%
10,867
-3,611
-25% -$1.01M
ARES icon
837
Ares Management
ARES
$33.6B
$2.8M ﹤0.01%
19,330
-514
-3% -$88.8K
DYN icon
838
Dyne Therapeutics
DYN
$4.85B
$2.78M ﹤0.01%
242,825
+95,823
+65% +$1.37M
WBD icon
839
Warner Bros
WBD
$69.5B
$2.77M ﹤0.01%
258,257
-13,681
-5% -$143K
KB icon
840
KB Financial Group
KB
$41.8B
$2.76M ﹤0.01%
51,683
+6,552
+15% +$378K
ES icon
841
Eversource Energy
ES
$27.2B
$2.76M ﹤0.01%
45,084
+18
+0% +$1.07K
GEHC icon
842
GE HealthCare
GEHC
$33.4B
$2.75M ﹤0.01%
34,321
-3,748
-10% -$322K
EVRG icon
843
Evergy
EVRG
$19.3B
$2.74M ﹤0.01%
40,316
+3,459
+9% +$226K
INVH icon
844
Invitation Homes
INVH
$18B
$2.72M ﹤0.01%
78,853
+8,435
+12% +$273K
CRNX icon
845
Crinetics Pharmaceuticals
CRNX
$8.96B
$2.69M ﹤0.01%
77,461
+48,100
+164% +$1.8M
VICI icon
846
VICI Properties
VICI
$29B
$2.69M ﹤0.01%
82,457
-5,069
-6% -$156K
CC icon
847
Chemours
CC
$2.28B
$2.69M ﹤0.01%
195,751
-65,450
-25% -$1.09M
ALB.PRA icon
848
Albemarle Corp Depositary Shares
ALB.PRA
$2.49B
$2.64M ﹤0.01%
+73,518
New +$2.9M
LTC
849
LTC Properties
LTC
$2.1B
$2.64M ﹤0.01%
74,977
-1,524
-2% -$53K
IFF icon
850
International Flavors & Fragrances
IFF
$21.4B
$2.62M ﹤0.01%
34,226
+1,591
+5% +$131K
32 33
34
35 36

Similar funds

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Schroder Investment Management Group's Q1 2025 Portfolio in Review

As of Q1 2025, Schroder Investment Management Group held 1,277 positions worth $99.1B, down 5.1% from $104B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Schroder Investment Management Group's Q1 2025 filing shows 83 new, 445 increased, 587 reduced and 91 closed positions. Its largest new stake was Arista Networks: 9,143,531 shares worth $708M. The largest sale was Merck, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Financials and Communication Services.

  • Schroder Investment Management Group's largest Q1 2025 buy was Arista Networks: 9,143,531 shares worth $708M.
  • Schroder Investment Management Group added most to Broadcom in Q1 2025, an estimated $406M increase.
  • Schroder Investment Management Group's biggest Q1 2025 reduction was Merck, cutting an estimated $325M.
  • Schroder Investment Management Group fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $62M.
  • Schroder Investment Management Group's ten largest holdings make up 28% of its $99.1B portfolio in Q1 2025.
  • Schroder Investment Management Group opened 83 new positions and closed 91 in Q1 2025.
  • Schroder Investment Management Group's portfolio value fell 5.1% quarter-over-quarter to $99.1B.

Based on Schroder Investment Management Group's 13F filing for Q1 2025, filed 13 May 2025.